vs
FIRST US BANCSHARES, INC.（FUSB）与Arcus Biosciences, Inc.（RCUS）财务数据对比。点击上方公司名可切换其他公司
Arcus Biosciences, Inc.的季度营收约是FIRST US BANCSHARES, INC.的1.1倍（$11.0M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -963.6%，领先984.1%），FIRST US BANCSHARES, INC.同比增速更快（7.1% vs -52.2%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $-121.0M），过去两年Arcus Biosciences, Inc.的营收复合增速更高（4.9% vs 2.6%）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
FUSB vs RCUS — 直观对比
营收规模更大
RCUS
是对方的1.1倍
$10.4M
营收增速更快
FUSB
高出59.2%
-52.2%
净利率更高
FUSB
高出984.1%
-963.6%
自由现金流更多
FUSB
多$130.1M
$-121.0M
两年增速更快
RCUS
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $11.0M |
| 净利润 | $2.1M | $-106.0M |
| 毛利率 | — | — |
| 营业利润率 | 28.1% | -1036.4% |
| 净利率 | 20.4% | -963.6% |
| 营收同比 | 7.1% | -52.2% |
| 净利润同比 | 24.2% | -12.8% |
| 每股收益（稀释后） | $0.36 | $-0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBRCUS
| Q4 25 | $10.4M | $11.0M | ||
| Q3 25 | $10.5M | $6.0M | ||
| Q2 25 | $10.3M | $8.0M | ||
| Q1 25 | $9.8M | $8.0M | ||
| Q4 24 | $9.7M | $23.0M | ||
| Q3 24 | $10.1M | $7.0M | ||
| Q2 24 | $10.0M | $11.0M | ||
| Q1 24 | $9.9M | $10.0M |
净利润FUSBRCUS
| Q4 25 | $2.1M | $-106.0M | ||
| Q3 25 | $1.9M | $-135.0M | ||
| Q2 25 | $155.0K | $0 | ||
| Q1 25 | $1.8M | $-112.0M | ||
| Q4 24 | $1.7M | $-94.0M | ||
| Q3 24 | $2.2M | $-92.0M | ||
| Q2 24 | $2.1M | $-93.0M | ||
| Q1 24 | $2.1M | $-4.0M |
营业利润率FUSBRCUS
| Q4 25 | 28.1% | -1036.4% | ||
| Q3 25 | 23.9% | -2366.7% | ||
| Q2 25 | 1.6% | -100.0% | ||
| Q1 25 | 23.8% | -1525.0% | ||
| Q4 24 | 23.8% | -447.8% | ||
| Q3 24 | 29.2% | -1500.0% | ||
| Q2 24 | 27.4% | -963.6% | ||
| Q1 24 | 27.8% | -160.0% |
净利率FUSBRCUS
| Q4 25 | 20.4% | -963.6% | ||
| Q3 25 | 18.4% | -2250.0% | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 18.1% | -1400.0% | ||
| Q4 24 | 17.6% | -408.7% | ||
| Q3 24 | 22.0% | -1314.3% | ||
| Q2 24 | 21.2% | -845.5% | ||
| Q1 24 | 21.3% | -40.0% |
每股收益（稀释后）FUSBRCUS
| Q4 25 | $0.36 | $-0.88 | ||
| Q3 25 | $0.32 | $-1.27 | ||
| Q2 25 | $0.03 | $0.00 | ||
| Q1 25 | $0.29 | $-1.14 | ||
| Q4 24 | $0.29 | $-1.07 | ||
| Q3 24 | $0.36 | $-1.00 | ||
| Q2 24 | $0.34 | $-1.02 | ||
| Q1 24 | $0.34 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $222.0M |
| 总债务越低越好 | $10.9M | $99.0M |
| 股东权益账面价值 | $105.6M | $631.0M |
| 总资产 | $1.2B | $1.1B |
| 负债/权益比越低杠杆越低 | 0.10× | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资FUSBRCUS
| Q4 25 | $73.5M | $222.0M | ||
| Q3 25 | $54.7M | $238.0M | ||
| Q2 25 | $54.0M | $248.0M | ||
| Q1 25 | $56.0M | $192.0M | ||
| Q4 24 | $47.2M | $150.0M | ||
| Q3 24 | $82.3M | $201.0M | ||
| Q2 24 | $58.2M | $156.0M | ||
| Q1 24 | $60.2M | $185.0M |
总债务FUSBRCUS
| Q4 25 | $10.9M | $99.0M | ||
| Q3 25 | $10.9M | $98.0M | ||
| Q2 25 | $10.9M | $97.0M | ||
| Q1 25 | $10.9M | $48.0M | ||
| Q4 24 | $10.9M | $48.0M | ||
| Q3 24 | $10.9M | $47.0M | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $10.8M | — |
股东权益FUSBRCUS
| Q4 25 | $105.6M | $631.0M | ||
| Q3 25 | $104.2M | $436.0M | ||
| Q2 25 | $101.9M | $549.0M | ||
| Q1 25 | $101.2M | $531.0M | ||
| Q4 24 | $98.6M | $485.0M | ||
| Q3 24 | $98.5M | $565.0M | ||
| Q2 24 | $93.8M | $635.0M | ||
| Q1 24 | $92.3M | $707.0M |
总资产FUSBRCUS
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.1B | $974.0M | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $1.1B | $1.3B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.1B | $1.3B |
负债/权益比FUSBRCUS
| Q4 25 | 0.10× | 0.16× | ||
| Q3 25 | 0.10× | 0.22× | ||
| Q2 25 | 0.11× | 0.18× | ||
| Q1 25 | 0.11× | 0.09× | ||
| Q4 24 | 0.11× | 0.10× | ||
| Q3 24 | 0.11× | 0.08× | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-120.0M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $-121.0M |
| 自由现金流率自由现金流/营收 | 87.2% | -1100.0% |
| 资本支出强度资本支出/营收 | 31.1% | 9.1% |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | — |
8季度趋势，按日历期对齐
经营现金流FUSBRCUS
| Q4 25 | $12.3M | $-120.0M | ||
| Q3 25 | $4.2M | $-97.0M | ||
| Q2 25 | $3.9M | $-133.0M | ||
| Q1 25 | $1.8M | $-132.0M | ||
| Q4 24 | $7.8M | $-100.0M | ||
| Q3 24 | $1.9M | $26.0M | ||
| Q2 24 | $2.5M | $-94.0M | ||
| Q1 24 | $825.0K | $-2.0M |
自由现金流FUSBRCUS
| Q4 25 | $9.1M | $-121.0M | ||
| Q3 25 | $3.6M | — | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $1.7M | $-133.0M | ||
| Q4 24 | $5.7M | $-101.0M | ||
| Q3 24 | $1.3M | $25.0M | ||
| Q2 24 | $2.3M | — | ||
| Q1 24 | $-142.0K | $-6.0M |
自由现金流率FUSBRCUS
| Q4 25 | 87.2% | -1100.0% | ||
| Q3 25 | 34.2% | — | ||
| Q2 25 | 16.0% | — | ||
| Q1 25 | 17.2% | -1662.5% | ||
| Q4 24 | 58.2% | -439.1% | ||
| Q3 24 | 12.7% | 357.1% | ||
| Q2 24 | 23.5% | — | ||
| Q1 24 | -1.4% | -60.0% |
资本支出强度FUSBRCUS
| Q4 25 | 31.1% | 9.1% | ||
| Q3 25 | 5.9% | 0.0% | ||
| Q2 25 | 21.8% | 0.0% | ||
| Q1 25 | 0.7% | 12.5% | ||
| Q4 24 | 21.6% | 4.3% | ||
| Q3 24 | 6.6% | 14.3% | ||
| Q2 24 | 2.0% | 0.0% | ||
| Q1 24 | 9.8% | 40.0% |
现金转化率FUSBRCUS
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUSB
暂无分部数据
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
